The dexamethasone suppression test and mood following stroke

Area of Science:

• Neurology
• Psychiatry
• Endocrinology

Background:

• Poststroke depression is a common complication.
• The Dexamethasone Suppression Test (DST) is a biomarker used in depression research.
• Understanding DST performance in stroke patients is crucial.

Purpose of the Study:

• To evaluate the Dexamethasone Suppression Test (DST) in acute and chronic stroke patients.
• To determine the association between DST nonsuppression and poststroke depression.
• To assess the sensitivity and specificity of DST in this population.

Main Methods:

• Administered DST to 65 acute and chronic stroke patients.
• Utilized DSM-III criteria for major depression diagnosis.
• Analyzed the relationship between DST results and depression in patients within one year of stroke.

Main Results:

• Nonsuppression on DST was significantly linked to poststroke depression in patients within one year of stroke.
• DST demonstrated 67% sensitivity and 70% specificity.
• False positive DST results in stroke patients correlated with larger lesion volumes.

Conclusions:

• DST may aid in identifying poststroke depression subtypes for research.
• Limited clinical utility of DST in stroke patients due to false positives.
• Large lesion volume is a potential confounder for DST results in stroke survivors.